InsidersTradesSigma
Follow the 한화생명 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Banks sector, 한화생명 has published 5 insider filings. Market capitalisation: €3,328.7bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 이종호. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Hanwha Life is a South Korean insurance company that provides various life insurance products and financial services. It is listed on the Korea Exchange, XKRX.